AXA SA (AXA.DE) Stock Fundamental Analysis
FRA:AXA - Deutsche Boerse Ag - FR0000120628 - Common Stock - Currency: EUR
We assign a fundamental rating of 5 out of 10 to AXA. AXA was compared to 33 industry peers in the Insurance industry. Both the profitability and the financial health of AXA get a neutral evaluation. Nothing too spectacular is happening here. AXA has a correct valuation and a medium growth rate. Finally AXA also has an excellent dividend rating. This makes AXA very considerable for dividend investing!
1. Profitability
1.1 Basic Checks
AXA had positive earnings in the past year.
AXA had a positive operating cash flow in the past year.
AXA had positive earnings in each of the past 5 years.
In the past 5 years AXA always reported a positive cash flow from operatings.
1.2 Ratios
AXA's Return On Assets of 1.12% is in line compared to the rest of the industry. AXA outperforms 55.56% of its industry peers.
The Return On Equity of AXA (15.16%) is better than 63.89% of its industry peers.
With a Return On Invested Capital value of 1.32%, AXA perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for AXA is in line with the industry average of 2.25%.
The 3 year average ROIC (1.23%) for AXA is below the current ROIC(1.32%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.12% | ||
| ROE | 15.16% | ||
| ROIC | 1.32% |
ROA(3y)1.01%
ROA(5y)0.77%
ROE(3y)12.73%
ROE(5y)9.51%
ROIC(3y)1.23%
ROIC(5y)1.01%
1.3 Margins
AXA has a Profit Margin (8.20%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of AXA has grown nicely.
AXA's Operating Margin of 11.69% is in line compared to the rest of the industry. AXA outperforms 55.56% of its industry peers.
AXA's Operating Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.69% | ||
| PM (TTM) | 8.2% | ||
| GM | N/A |
OM growth 3Y23.76%
OM growth 5Y4.76%
PM growth 3Y46.22%
PM growth 5Y36.38%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AXA is destroying value.
The number of shares outstanding for AXA has been reduced compared to 1 year ago.
The number of shares outstanding for AXA has been reduced compared to 5 years ago.
Compared to 1 year ago, AXA has about the same debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.35, we must say that AXA is in the distress zone and has some risk of bankruptcy.
With an excellent Altman-Z score value of 0.35, AXA belongs to the best of the industry, outperforming 91.67% of the companies in the same industry.
AXA has a debt to FCF ratio of 3.32. This is a good value and a sign of high solvency as AXA would need 3.32 years to pay back of all of its debts.
The Debt to FCF ratio of AXA (3.32) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.57 indicates that AXA is somewhat dependend on debt financing.
The Debt to Equity ratio of AXA (0.57) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 3.32 | ||
| Altman-Z | 0.35 |
ROIC/WACC0.13
WACC10.32%
2.3 Liquidity
A Current Ratio of 1.00 indicates that AXA should not have too much problems paying its short term obligations.
AXA has a better Current ratio (1.00) than 80.56% of its industry peers.
AXA has a Quick Ratio of 1.00. This is a normal value and indicates that AXA is financially healthy and should not expect problems in meeting its short term obligations.
AXA has a better Quick ratio (1.00) than 80.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
AXA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.49%, which is quite good.
AXA shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 32.03% yearly.
Looking at the last year, AXA shows a very negative growth in Revenue. The Revenue has decreased by -11.35% in the last year.
Measured over the past years, AXA shows a decrease in Revenue. The Revenue has been decreasing by -4.60% on average per year.
EPS 1Y (TTM)17.49%
EPS 3Y35.79%
EPS 5Y32.03%
EPS Q2Q%4.47%
Revenue 1Y (TTM)-11.35%
Revenue growth 3Y-9.14%
Revenue growth 5Y-4.6%
Sales Q2Q%-21.85%
3.2 Future
Based on estimates for the next years, AXA will show a small growth in Earnings Per Share. The EPS will grow by 5.80% on average per year.
The Revenue is expected to grow by 5.65% on average over the next years.
EPS Next Y7.01%
EPS Next 2Y8.89%
EPS Next 3Y8.1%
EPS Next 5Y5.8%
Revenue Next Year-9.57%
Revenue Next 2Y-2.36%
Revenue Next 3Y-0.04%
Revenue Next 5Y5.65%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 12.01, the valuation of AXA can be described as correct.
AXA's Price/Earnings ratio is a bit cheaper when compared to the industry. AXA is cheaper than 61.11% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.35, AXA is valued rather cheaply.
A Price/Forward Earnings ratio of 9.63 indicates a reasonable valuation of AXA.
61.11% of the companies in the same industry are more expensive than AXA, based on the Price/Forward Earnings ratio.
AXA is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.01 | ||
| Fwd PE | 9.63 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AXA indicates a somewhat cheap valuation: AXA is cheaper than 61.11% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 10.63 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
AXA's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The decent profitability rating of AXA may justify a higher PE ratio.
PEG (NY)1.71
PEG (5Y)0.37
EPS Next 2Y8.89%
EPS Next 3Y8.1%
5. Dividend
5.1 Amount
AXA has a Yearly Dividend Yield of 5.56%, which is a nice return.
AXA's Dividend Yield is a higher than the industry average which is at 4.64.
Compared to an average S&P500 Dividend Yield of 2.33, AXA pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.56% |
5.2 History
The dividend of AXA has a limited annual growth rate of 4.19%.
Dividend Growth(5Y)4.19%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
62.10% of the earnings are spent on dividend by AXA. This is not a sustainable payout ratio.
The dividend of AXA is growing, but earnings are growing more, so the dividend growth is sustainable.
DP62.1%
EPS Next 2Y8.89%
EPS Next 3Y8.1%
FRA:AXA (3/7/2025, 7:00:00 PM)
38.78
+0.12 (+0.31%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners36.79%
Inst Owner ChangeN/A
Ins Owners0.09%
Ins Owner ChangeN/A
Market Cap85.89B
Analysts80
Price Target41.33 (6.58%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 5.56% |
Yearly Dividend1.76
Dividend Growth(5Y)4.19%
DP62.1%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.21%
PT rev (3m)2.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.18%
EPS NY rev (3m)-1.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)4.65%
Revenue NY rev (3m)0.01%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 12.01 | ||
| Fwd PE | 9.63 | ||
| P/S | 0.98 | ||
| P/FCF | 10.63 | ||
| P/OCF | 10.03 | ||
| P/B | 1.81 | ||
| P/tB | 3.5 | ||
| EV/EBITDA | N/A |
EPS(TTM)3.23
EY8.33%
EPS(NY)4.03
Fwd EY10.39%
FCF(TTM)3.65
FCFY9.41%
OCF(TTM)3.86
OCFY9.97%
SpS39.5
BVpS21.37
TBVpS11.07
PEG (NY)1.71
PEG (5Y)0.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.12% | ||
| ROE | 15.16% | ||
| ROCE | 1.63% | ||
| ROIC | 1.32% | ||
| ROICexc | 1.37% | ||
| ROICexgc | 1.79% | ||
| OM | 11.69% | ||
| PM (TTM) | 8.2% | ||
| GM | N/A | ||
| FCFM | 9.24% |
ROA(3y)1.01%
ROA(5y)0.77%
ROE(3y)12.73%
ROE(5y)9.51%
ROIC(3y)1.23%
ROIC(5y)1.01%
ROICexc(3y)1.28%
ROICexc(5y)1.05%
ROICexgc(3y)1.64%
ROICexgc(5y)1.33%
ROCE(3y)1.52%
ROCE(5y)1.25%
ROICexcg growth 3Y24.63%
ROICexcg growth 5Y6.98%
ROICexc growth 3Y21.16%
ROICexc growth 5Y7.2%
OM growth 3Y23.76%
OM growth 5Y4.76%
PM growth 3Y46.22%
PM growth 5Y36.38%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.14
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.57 | ||
| Debt/FCF | 3.32 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | 0.55% | ||
| Interest Coverage | 1.51 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 112.61% | ||
| Current Ratio | 1 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 0.35 |
F-Score7
WACC10.32%
ROIC/WACC0.13
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)0.37%
Cap/Sales(5y)0.36%
Profit Quality(3y)112.32%
Profit Quality(5y)257.76%
High Growth Momentum
Growth
EPS 1Y (TTM)17.49%
EPS 3Y35.79%
EPS 5Y32.03%
EPS Q2Q%4.47%
EPS Next Y7.01%
EPS Next 2Y8.89%
EPS Next 3Y8.1%
EPS Next 5Y5.8%
Revenue 1Y (TTM)-11.35%
Revenue growth 3Y-9.14%
Revenue growth 5Y-4.6%
Sales Q2Q%-21.85%
Revenue Next Year-9.57%
Revenue Next 2Y-2.36%
Revenue Next 3Y-0.04%
Revenue Next 5Y5.65%
EBIT growth 1Y4.29%
EBIT growth 3Y12.44%
EBIT growth 5Y-0.05%
EBIT Next Year23.05%
EBIT Next 3Y8.68%
EBIT Next 5YN/A
FCF growth 1Y9.42%
FCF growth 3Y-33.47%
FCF growth 5Y-1.8%
OCF growth 1Y11.23%
OCF growth 3Y-32.45%
OCF growth 5Y-1.79%